In this 1.5 hour intermediate to advanced level discussion on the qualitative assessment of pharmaceutical compounds including: the history of OEBs, developing an enrolment criteria matrix, and why it is important to linking these bands to a control matrix. We will also discuss how banding systems have been used and misused over the years. Sample data sets and compound-specific examples will be reviewed.Who Should Attend
The webinars will be led by Bob Sussman, Ph.D., DABT, Tracy Kimmel, Ph.D., DABT and Elizabeth Vancza, Ph.D., DABT, SDSRP of SafeBridge Consultants, Inc., the premier occupational health and safety consulting firm to the bio- and pharmaceutical industries, especially with regard to potent compounds. Each pharmaceutical occupational toxicology and industrial hygiene experience in the systematic and scientific approach to safe handling of potent active pharmaceutical ingredients and drug products.
Note: The course fee is per attendee. Recording the training course is strictly prohibited.
For registration questions please contact Kent Rader at Kent.Rader@safebridge.com